The dialysis modality mix in China is quite different from Hong Kong (HK). A recent article [1] about global differ-ences in dialysis modality mix showed interesting differ-ences in peritoneal dialysis (PD) prevalence in 36 countries (reported 2003–05) but omitted China and HK in its report. The Gross Domestic Product (GDP) per capita on health-care and the reimbursement rate of renal services were re-garded as the main determinants of the dialysis modality mix, although diabetes was associated with significantly less use of PD at Day 91. Diabetes is a common cause of end-stage kidney disease (ESKD) in the Orient. It is interesting that HK has a ‘PD first ’ policy, where 90 % of patients are on PD. Yet, in China, with a population of 1.3 bi...
Abstract The mission of Kidney Disease: Improving Global Outcomes (KDIGO) is to improve the care and...
Background: Hemodialysis (HD) and peritoneal dialysis (PD) are important renal replacement treatment...
[[abstract]]ABSTRACT: Studies comparing mortality for Asian populations with end-stage renal disease...
The dialysis modality mix in China is quite different from Hong Kong (HK). A recent article [1] abou...
Peritoneal dialysis (PD) is an effective renal replacement therapy; however, its penetration rate in...
Asia is the largest and most populated continent in the world, with a high burden of kidney failure....
Background: An increase in the dialysis programme expenditure is expected in most countries given th...
The socioeconomic statuses of Asian countries are diverse and government reimbursement policies for ...
Introduction: Understanding the status and trends of patients with ESKD is important to evaluate and...
Prevalence and incidence of peritoneal dialysis (PD) in Asia are both increasing, but the increase i...
Objective. We compared patient characteristics, dialysis practice patterns and outcomes of peritonea...
The usage of three x 2 liter daily exchanges is adopted as the standard CAPD regime in Hong Kong ove...
[[abstract]]OBJECTIVES: In Taiwan, peritoneal dialysis (PD) and haemodialysis are fully accessible t...
The number of patients with end-stage renal disease (ESRD) has rapidly increased, as has the cost of...
Opportunities for a chronic disease outreach program in China The comparison of the prevalence of pa...
Abstract The mission of Kidney Disease: Improving Global Outcomes (KDIGO) is to improve the care and...
Background: Hemodialysis (HD) and peritoneal dialysis (PD) are important renal replacement treatment...
[[abstract]]ABSTRACT: Studies comparing mortality for Asian populations with end-stage renal disease...
The dialysis modality mix in China is quite different from Hong Kong (HK). A recent article [1] abou...
Peritoneal dialysis (PD) is an effective renal replacement therapy; however, its penetration rate in...
Asia is the largest and most populated continent in the world, with a high burden of kidney failure....
Background: An increase in the dialysis programme expenditure is expected in most countries given th...
The socioeconomic statuses of Asian countries are diverse and government reimbursement policies for ...
Introduction: Understanding the status and trends of patients with ESKD is important to evaluate and...
Prevalence and incidence of peritoneal dialysis (PD) in Asia are both increasing, but the increase i...
Objective. We compared patient characteristics, dialysis practice patterns and outcomes of peritonea...
The usage of three x 2 liter daily exchanges is adopted as the standard CAPD regime in Hong Kong ove...
[[abstract]]OBJECTIVES: In Taiwan, peritoneal dialysis (PD) and haemodialysis are fully accessible t...
The number of patients with end-stage renal disease (ESRD) has rapidly increased, as has the cost of...
Opportunities for a chronic disease outreach program in China The comparison of the prevalence of pa...
Abstract The mission of Kidney Disease: Improving Global Outcomes (KDIGO) is to improve the care and...
Background: Hemodialysis (HD) and peritoneal dialysis (PD) are important renal replacement treatment...
[[abstract]]ABSTRACT: Studies comparing mortality for Asian populations with end-stage renal disease...